Ming‐Qing Li
Impact in
- Obstetrics and Gynecology top 0.1%
- Pregnancy and preeclampsia studies
- Uterine Myomas and Treatments
- Endometrial and Cervical Cancer Treatments
- Reproductive Medicine top 0.2%
- Endometriosis Research and Treatment
Papers in
-
- Pregnancy and preeclampsia studies 56
- Endometrial and Cervical Cancer Treatments 27
- Uterine Myomas and Treatments 25
-
- Endometriosis Research and Treatment 105
Ming‐Qing Li
294 papers receiving 7.6k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Obstetrics and Gynecology 2.3k
- Reproductive Medicine 2.3k
- Immunology 3.5k
- Cancer Research 866
- Cell Biology 615
Countries citing papers authored by Ming‐Qing Li
This map shows the geographic impact of Ming‐Qing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Qing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Qing Li more than expected).
Fields of papers citing papers by Ming‐Qing Li
This network shows the impact of papers produced by Ming‐Qing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Qing Li. The network helps show where Ming‐Qing Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming‐Qing Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 6 | |
| 11 | Generative artificial intelligence and its applications in materials science: Current situation and future perspectives Hit paper breakdown → | 2023 | 164 |
| 12 | 2023 | 8 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 4 | |
| 15 | 2023 | 2 | |
| 16 | 2022 | 118 | |
| 17 | 2021 | 117 | |
| 18 | 2021 | 3 | |
| 19 | 2020 | 11 | |
| 20 | 2017 | 65 |
About Ming‐Qing Li
Ming‐Qing Li is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Immunology, Cancer Research and Biological Psychiatry, having authored 308 papers that have together received 7.7k indexed citations. Recurring topics across this work include Reproductive System and Pregnancy (157 papers), Endometriosis Research and Treatment (105 papers), Pregnancy and preeclampsia studies (56 papers), Endometrial and Cervical Cancer Treatments (27 papers), Uterine Myomas and Treatments (25 papers), Pregnancy and Medication Impact (18 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Preterm Birth and Chorioamnionitis (10 papers). The work is most often cited by research in Obstetrics and Gynecology (2.3k citations), Reproductive Medicine (2.3k citations), Immunology (3.5k citations), Cancer Research (866 citations) and Cell Biology (615 citations). Ming‐Qing Li has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Da‐Jin Li, Jie Mei, Hui‐Li Yang, Wen‐Jie Zhou, Kai‐Kai Chang, Liping Jin, Xiao‐Yong Zhu, Jun Shao, Feng Xie and Huaping Li. Their work appears in journals such as American Journal of Reproductive Immunology, Reproduction, Journal of Reproductive Immunology, International Journal of Biological Sciences and Biomolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.